medigraphic.com
Instituto Nacional de Salud Pública

2019, Número 6

<< Anterior Siguiente >>

salud publica mex 2019; 61 (6)


Prevalencia, diagnóstico y control de hipertensión arterial en adultos mexicanos en condición de vulnerabilidad. Resultados de la Ensanut 100k

Campos-Nonato I, Hernández-Barrera L, Flores-Coria A, Gómez-Álvarez E, Barquera S

Idioma: Español
Referencias bibliográficas: 28
Paginas: 888-897
Archivo PDF: 358.08 Kb.


RESUMEN

Objetivo. Describir la prevalencia de hipertensión arterial (HTA) en adultos en condición de vulnerabilidad, el porcentaje de ellos con diagnóstico previo y la proporción con control adecuado. Material y métodos. Se midió la tensión arterial a 7 838 adultos participantes en la Ensanut 100k. Se clasificó como hipertensos a quienes autorreportaron el diagnóstico de HTA o presentaban tensión arterial sistólica (TAS) ≥130mmHg o tensión arterial diastólica (TAD) ≥80mmHg. Se consideró tensión arterial controlada cuando la TAS fue ‹130mmHg y la TAD ‹80mmHg. Resultados. La prevalencia de HTA en adultos en condición de vulnerabilidad fue de 49.2%, de los cuales 54.7% desconocía tener HTA. De los hipertensos que recibían tratamiento farmacológico (69.0%), el 66.8% tuvo tensión arterial controlada. Conclusiones. Casi la mitad de los adultos mexicanos en condición de vulnerabilidad tiene HTA y de ellos, más de la mitad desconoce que tiene esta enfermedad. Asimismo, un tercio de los adultos hipertensos tiene un inadecuado control de su enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. A global brief on hypertension. Silent killer, global public health crisis. Ginebra:WHO, 2013 [citado abril, 2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/79059/ WHO_DCO_WHD_2013.2_eng.pdf?sequence=1

  2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. https://doi.org/10.1016/S0140-6736(12)61766-8

  3. World Health Organization. Chapter 1. Burden: mortality, morbidity and risk factors. En: World Health Organization. Global status report on noncommunicable diseases 2010. Ginebra:WHO, 2011:9-32 [citado abril, 2019]. Disponible en: https://www.who.int/nmh/publications/ncd_report_ chapter1.pdf?ua=1

  4. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233-43. https://doi.org/10.21149/8813

  5. Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, et al. Wealth and cardiovascular health: a cross-sectional study of wealthrelated inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health. 2016;15(1):199. https://doi.org/10.1186/s12939-016-0478-6

  6. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Gaona-Pineda EB, Gómez-Acosta LM, Mendoza Alvarado LR, et al. Metodología de la Encuesta Nacional de Salud y Nutrición para localidades con menos de 100 000 habitantes (Ensanut 100k). Salud Publica Mex. 2019;61(5):678-84. https:// doi.org/10.21149/10539

  7. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142-61. https://doi. org/10.1161/01.HYP.0000150859.47929.8e

  8. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127-248. https://doi.org/10.1016/j.jacc.2017.11.006

  9. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507- 20. https://doi.org/10.1001/jama.2013.284427

  10. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923-94. https://doi. org/10.1016/S0140-6736(18)32225-6

  11. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol. 1996;25(6):1107-16. https://doi.org/10.1093/ije/25.6.1107

  12. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963-75. https://doi. org/10.1097/HJH.0b013e3283282f65

  13. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011;377(9765):568-77. https://doi.org/10.1016/S0140-6736(10)62036-3

  14. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. https://doi.org/10.1161/CIRCULATIONAHA. 115.018912

  15. Schiffrin EL. Global impact of the 2017 American College of Cardiology/ American Heart Association hypertension guidelines: A perspective from Canada. Circulation. 2018;137(9):883-5. https://doi.org/10.1161/ CIRCULATIONAHA.117.032849

  16. Wang JG, Liu L. Global impact of 2017 American College of Cardiology/ American Heart Association hypertension guidelines: A perspective from China. Circulation. 2018;137(6):546-8. https://doi.org/10.1161/CIRCULATIONAHA. 117.032890

  17. Kario K. Global impact of 2017 American Heart Association/American College of Cardiology hypertension guidelines: A perspective from Japan. Circulation. 2018;137(6):543-5. https://doi.org/10.1161/CIRCULATIONAHA. 117.032851

  18. Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018;27(3):176-81. https://doi.org/10.1097/ MNH.0000000000000404

  19. Wang J, Sun W, Wells GA, Li Z, Li T, Wu J, et al. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People’s Republic of China: A crosssectional study. PLoS One. 2018;13(4):e0195340. https://doi.org/10.1371/ journal.pone.0195340

  20. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: A systematic review and metaanalysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-7. https://doi.org/10.1097/HJH.0000000000000146

  21. Tedesco MA, Di Salvo G, Caputo S, Natale F, Ratti G, Iarussi D, Iacono A. Educational level and hypertension: How socioeconomic differences condition health care. J Hum Hypertens. 2001;15(10):727-31. https://doi. org/10.1038/sj.jhh.1001249

  22. Liu SY, Buka SL, Linkletter CD, Kawachi I, Kubzansky L, Loucks EB. The association between blood pressure and years of schooling versus educational credentials: Test of the sheepskin effect. Ann Epidemiol. 2011;21(2):128-38. https://doi.org/10.1016/j.annepidem.2010.11.004

  23. US Preventive Services Task Force. Screening for high blood pressure: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2007;147(11):783-6. https://doi.org/10.7326/0003- 4819-147-11-200712040-00009

  24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52. https://doi.org/10.1161/01.HYP.0000107251.49515.c2

  25. Di Giosia P, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A. Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Curr Atheroscler Rep. 2018;20(3):13. https://doi.org/10.1007/ s11883-018-0716-z

  26. Zhang Y, Moran AE. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70(4):736-42. https://doi.org/10.1161/HYPERTENSIONAHA. 117.09801

  27. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. https://doi. org/10.1093/eurheartj/eht151

  28. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humarán I, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59:299-305. https://doi.org/10.21149/8593




2020     |     www.medigraphic.com